Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Open Access Journal of Gynecology Research Article 5 min read

The Ratio of Medullary Breast Carcinoma (MBC) to Invasive Ductal Carcinoma (IDC) is Comparable in Developed and Underdeveloped Countries

Wilson IBO*
* Corresponding author
ISSN: 2474-9230  10.23880/oajg-16000S2-001  Received: January 11, 2017  Published: February 03, 2017
  views
 26 references
 1 table
PDF
Keywords
Breast Carcinoma Medullary Invasive ductal Developed Underdeveloped countries Equal ratio
Abstract

My interest in the epidemiology of the female breast diseases ranged from 1979 to 2016. This interest included adolescent masses, onchocerciasis, fibroadenoma, dysplasia versus malignancy, self-examination, regression, carcinosarcoma, role of family doctors, and comparison of its epidemiology in Sweden and Nigeria. Moreover, lymph node biopsy was used to confirm the success which has followed health education in the community. The historical element was the operation for massive lipoma by two eponymous giants; this was published in 1846. Apart from this multifaceted background, the current paper compares the ratio of medullary carcinoma of the breast (MCB) and of invasive ductal carcinoma (IDC) not only in the developed but also in the developing countries. Interestingly, both were found to be equal.

Introduction

The author has long been interested in the study of diseases of the female breast. Indeed, they have extended from 1979 to 2016. They covered multivariagated areas as follows: adolescence [1], Paget’s disease [2], onchocerciasis [3], fibroadenoma [4], cancer regression [5], and carcinosarcoma [6]. The lymph node biopsy trend confirms that health education is succeeding in the community [7]. Moreover, there was the history of bulky lipoma operated on by two surgical giants in 1846 [8]. I have followed the emphasis laid by others in diagnosing medullary breast carcinoma (MBC). Thus, Malyuchik and Kiyamora [9] of Ukraine emphasized that “Lymphocytic infiltration is a unique feature of MBC.” From the UK, Marginean and her colleagues [10] used repeatedly the expression of “Prominent inflammation.” As regards Iran [11], the optional language was being “surrounded by dense lymphocytic infiltration.” Incidentally, the literature also revealed the trend towards comparing MBC and invasive ductal carcinoma (IDC). Thus, from Korea [12], India [13] and China [14], there have been decisive comparisons. For instance, the last named authors were emphatic concerning the “Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma.”

Comparable Data

I am persuaded that these results stood out so well that I could compare them with those of my developing community. In sum, their broad base followed the establishment of a Reference Pathology Laboratory at Enugu, the Capital of the Eastern Region of Nigeria. The physicians working in various hospitals throughout the community were encouraged to use a printed “Laboratory Request Form.” This Form expressly required name of the patient, age, sex, complaint and duration, site of any lesion, investigations, nature of the material biopsied and the provisional diagnosis. After professional training at the famous Glasgow Western Infirmary [15], I became the Head of the Enugu Institution in 1970. One of my decisions was to have a personal copy of all documented materials! Therefore, it turned out that I was able to follow the principles laid out by a Birmingham (UK) group [16] to the effect that a histopathology data pool facilitates epidemiological analysis. The first fruit of these analyses was the collection of 36 papers written in the early 1970s as a Doctoral Thesis entitled “Studies on the geographical pathology of the Igbos of Nigeria” [17]. In short, the present paper is a natural offshoot! Furthermore, it was relatively easy to compare my own materials with those from “13 International Breast Cancer Study Group (IBCSG) [18].” Perhaps, tabulating them hereunder is necessary (Table 1).

GroupTotalMBCRatio
International [18]1270912710.2%
Nigerian5655910.4%

Table 1: Comparison of International and Nigerian data

Discussion

These results show that, as regards MBC cases, both international and local trends are comparable. Therefore, it remains for future studies to confirm or confute this conclusion using such fine different parameters as genomic profile [19], microglobulin expression [20], anatomo-radiological carrelation [21], and MRI findings [22]. Earlier on, precisely in 1977, Ridolfi and associates [23] wrote as follows: “medullary carcinoma is an infrequent type of mammary duct carcinoma usually considered to have a better prognosis than the common forms of infiltrating duct carcinoma.” This conclusion was arrived at the Memorial Hospital by using records from 1955 through 1965. Incidentally, the present data are from

1970. Incidentally, it was some time ago argued in the UK that results obtained for distant hospitals are debatable [24]. I am persuaded that the local findings have proved to be worthwhile [25, 26]. As to the future, experience in the local hospital wards would be the appropriate research ground and not just their biopsies!

References

  1. Onuigbo WIB (1979) Adolescent breast masses in Nigerian Igbos. Am J Surg 137(3): 367-368.
  2. Onuigbo WIB (1985) Paget’s 1874 article on the breast. Modern misconceptions. Int J Dermatol 24(8): 537-538.
  3. Onuigbo WIB (2002) Breast lumps due to nodulation in onchocerciasis. Ebonyi Med J 1(1): 37-41.
  4. Onuigbo WIB (2003) Breast fibroadenoma in teenage females. Turk J Pediat 45(4): 326-328.
  5. Onuigbo WIB (2012) Spontaneous regression of breast carcinoma: review of English publications from 1753 to 1897. Oncol Rev 6(2): e22.
  6. Onuigbo WIB (2015) Epidemiologic analysis of the surgical specimens of breast carcinosarcomas examined at a Reference Laboratory in a Nigerian Community. Surg Res 1(1): 25-27.
  7. Onuigbo WIB (2015) Breast biopsy: the harvesting of lymph nodes presenting as lumps in a Nigerian community indicates that preventive cancer education is succeeding. J Cancer Prev Curr Res 3(5): 00095.
  8. Onuigbo WIB (2016) Massive breast lipoma operated on by two eponymous giants in 1846. J Gynecol Women’s Hlth 1(3): JGWAEID 5666.
  9. Malyuchik SS, Kiyamova RG (2008) Medullary breast carcinoma. Exp Oncol 30(2): 96-101.
  10. Marginean F, Rakha EA, Ho BC, Ellis IO, Lee AH (2010) Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Mod Pathol 23(10): 1357-1363.
  11. Zahir T, Shiryazdi SM, Vahidfar MR (2012) Medullary breast carcinoma in a 17 year-old female (Rare case report). Iranian J Pediat Hematol Oncol 12(1): 40-43.
  12. Park I, Kim J, Kim M, Bae SY, Lee SK, et al. (2013) Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma. J Breast Cancer 16(4): 417-425.
  13. Santosh T, Bal AK, Ptro MK, Choudhury A (1948) Medullary breast cancer carcinoma: A case report and review of literature. J Cancer Sci Ther 7: 142-144.
  14. Wang X, Jiang Y, Liu X, Li JJ, Song CG, et al. (2016) Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database. Oncotarget 7(16): 22665-22673.
  15. Lacyna LS (1988) The laboratory and the clinic: The impact of pathology on surgical diagnosis in the Glasgow Western Infirmary, 1875-1910. Bull Hist Med 62(3): 384-406.
  16. Macartney JC, Rollaston TP, Codling BW (1980) Use of a histopathology data pool for epidemiological analysis. J Clin Pathol 33: 351-353.
  17. Onuigbo WIB (1980) Studies on the geographical pathology of the Igbos of Nigeria. Glasgow University.
  18. Huober J, Gelber S, Goldhirsch A, Coates AS, Viale G, et al. (2012) Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol 23(11): 2843-2851.
  19. Kleer CG (2009) Carcinoma of the breast with medullary-like features: Diagnostic challenges and relationship with BRCA1 and EZH2 functions. Archives Pathol Lab Med 133(11): 1822-1825.
  20. Feinmesser M, Sulkes A, Morgenstern S, Jaqueline Sulkes, Sidi Stern, et al. (2000) HLA-DR and β2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities. J Clin Pathol 53: 286-291.
  21. Matheus VS, Kestelman FP, Canella EO, Maria CRD, Hilton AK (2008) Medullary breast carcinoma: anatomo-radiological correlation. Radiol Bras 41(6).
  22. Jeong SJ, Lim HS, Lee JS, Park MH, Yoon JH, et al. (2012) Medullary carcinoma of the breast: MRI findings. Am J Roentgenol 198(5): W482-W487.
  23. Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V (1977) Medullary carcinoma of the breast: A clinicopathologic study with 10 year follow-up. Cancer 40(4): 1365-1385.
  24. Lilleyman J (2002) From the president. Bull Roy Coll Pathol 117: 2-3.
  25. Onuigbo WIB, Mbanaso AU (2005) Urban histopathology service for a remote Nigerian hospital. Bull Roy Coll Pathol 132: 32-34.
  26. Onuigbo WIB, Anyaeze CM (2009) Biopsy service for surgical practice in mission hospital. Owerri Med J 3: 7-10.

Cite this article

BibTeX
APA
RIS
@article{wilson2017,
  title   = {The Ratio of Medullary Breast Carcinoma (MBC) to Invasive
Ductal Carcinoma (IDC) is Comparable in Developed and
Underdeveloped Countries},
  author  = {Wilson IBO},
  journal = {Open Access Journal of Gynecology},
  year    = {2017},
  volume  = {2},
  number  = {Special Issue 2},
  doi     = {10.23880/oajg-16000S2-001}
}
Wilson IBO (2017). The Ratio of Medullary Breast Carcinoma (MBC) to Invasive
Ductal Carcinoma (IDC) is Comparable in Developed and
Underdeveloped Countries. Open Access Journal of Gynecology, 2(Special Issue 2). https://doi.org/10.23880/oajg-16000S2-001
TY  - JOUR
TI  - The Ratio of Medullary Breast Carcinoma (MBC) to Invasive
Ductal Carcinoma (IDC) is Comparable in Developed and
Underdeveloped Countries
AU  - Wilson IBO
JO  - Open Access Journal of Gynecology
PY  - 2017
VL  - 2
IS  - Special Issue 2
DO  - 10.23880/oajg-16000S2-001
ER  -